Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
Conditions: Stereotactic Radiotherapy; Immunotherapy; Breast Cancer Interventions: Drug: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin); Drug: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin) Sponsors: Shengjing Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Immunotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research